Cite
MLA Citation
Susanne Wingert et al.. “Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors.” MAbs, vol. 13, no. 1, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100136727163.0x00000a